The scientific articles reviewed here focus on the innovative use of quaternary ammonium compounds (QACs) to combat methicillin-resistant Staphylococcus aureus (MRSA) and other antimicrobial-resistant (AMR) bacteria. The first article introduces a novel class of "bushy-tailed" multicationic quaternary phosphonium compounds (QPCs), which are structurally divergent from traditional QACs. These QPCs exhibit potent antimicrobial activity, with significantly improved minimum inhibitory concentrations (MICs) compared to conventional QACs, and favorable therapeutic indices, suggesting a promising alternative for infection control with lower mammalian toxicity.

The second article explores the development of self-assembling gemini quaternary ammonium-functionalized peptide nanoassemblies. These materials, created by conjugating antimicrobial gemini QACs with short hexapeptides, demonstrate multiple antibacterial mechanisms with low cytotoxicity and a reduced tendency for resistance development. This approach highlights the potential for peptide-based nanomaterials in addressing the challenge of AMR infections.

Additionally, the third article discusses the modification of pleuromutilins with quaternary ammonium groups to enhance targeting of liver and kidney tissues via organic cation transporters. This modification aims to improve the pharmacokinetics and reduce the organ toxicity of pleuromutilins, offering a new avenue for treating multidrug-resistant bacterial infections.

Collectively, these studies underscore the versatility and potential of QACs and their derivatives in developing new antimicrobial strategies. The innovative architectures and mechanisms of action presented in these articles provide valuable insights into the design of next-generation antimicrobials. These findings have significant implications for improving infection prevention and control, particularly in the face of rising antimicrobial resistance, and highlight the need for continued research and development in this field.